Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth. - Ray PC; Huggett M; Turner PA; Taylor M; Cleghorn LAT; Early J; Kumar A; Bonnett SA; Flint L; Joerss D; Johnson J; Korkegian A; et al. (ACS omega, 2021)